Erythropoietin Falls Short of Neuroprotection in Optic Neuritis ...Middle East

Medscape - News
A higher rate of conversion to multiple sclerosis in the placebo group offered a glimmer of hope for treatment in TONE, a phase 3 randomized trial, but caveats loom large. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Erythropoietin Falls Short of Neuroprotection in Optic Neuritis )

Apple Storegoogle play

Also on site :